NCT00508456 Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM Status TERMINATED Phase PHASE1
NCT00504660 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients Status COMPLETED Phase PHASE2
NCT00501891 Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma Status COMPLETED Phase PHASE2
NCT00479765 A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma Status TERMINATED Phase PHASE1/PHASE2
NCT00473408 The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas Status TERMINATED Phase N/A
NCT00441142 Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00412542 Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas Status COMPLETED Phase PHASE2
NCT00409214 Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma Status COMPLETED Phase PHASE2
NCT00402116 Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients Status COMPLETED Phase PHASE1/PHASE2
NCT00400322 Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection Status COMPLETED Phase NA
NCT00394628 AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme Status UNKNOWN Phase PHASE1/PHASE2
NCT00376103 Radiation Boost for Newly Diagnosed Glioblastoma Multiforme Status TERMINATED Phase PHASE1/PHASE2
NCT00323115 Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00311857 Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) Status UNKNOWN Phase PHASE1/PHASE2
NCT00301418 Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma Status COMPLETED Phase PHASE1/PHASE2
NCT00267592 Safety and Efficacy of Talampanel in Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00262730 Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM Status COMPLETED Phase PHASE2
NCT00243490 Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors Status WITHDRAWN Phase PHASE2